141 related articles for article (PubMed ID: 34995858)
21. Design, Synthesis and Evaluation of 2,4-Diaminoquinazoline Derivatives as Potential Tubulin Polymerization Inhibitors.
Herrera-Vázquez FS; Matadamas-Martínez F; Aguayo-Ortiz R; Dominguez L; Ramírez-Apan T; Yépez-Mulia L; Hernández-Luis F
ChemMedChem; 2020 Oct; 15(19):1802-1812. PubMed ID: 32686342
[TBL] [Abstract][Full Text] [Related]
22. The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in β-tubulin.
Yang J; Yan W; Yu Y; Wang Y; Yang T; Xue L; Yuan X; Long C; Liu Z; Chen X; Hu M; Zheng L; Qiu Q; Pei H; Li D; Wang F; Bai P; Wen J; Ye H; Chen L
J Biol Chem; 2018 Jun; 293(24):9461-9472. PubMed ID: 29691282
[TBL] [Abstract][Full Text] [Related]
23. Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site.
Eissa IH; Dahab MA; Ibrahim MK; Alsaif NA; Alanazi AZ; Eissa SI; Mehany ABM; Beauchemin AM
Bioorg Chem; 2021 Jul; 112():104965. PubMed ID: 34020238
[TBL] [Abstract][Full Text] [Related]
24. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
Ahmadi S; Habibpour E
Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, and biological evaluation of novel diphenylamine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site.
Yan XY; Leng JF; Chen TT; Zhao YJ; Kong LY; Yin Y
Eur J Med Chem; 2022 Jul; 237():114372. PubMed ID: 35447432
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of indole-2-carbohydrazides and thiazolidinyl-indole-2-carboxamides as potent tubulin polymerization inhibitors.
Kazan F; Yagci ZB; Bai R; Ozkirimli E; Hamel E; Ozkirimli S
Comput Biol Chem; 2019 Jun; 80():512-523. PubMed ID: 31185422
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and bioevaluation of novel trifluoromethylquinoline derivatives as tubulin polymerization inhibitors.
Zhang S; Mo M; Lv M; Xia W; Liu K; Yu G; Yu J; Xu G; Zeng X; Cheng S; Xu B; Luo H; Meng X
Future Med Chem; 2023 Nov; 15(21):1967-1986. PubMed ID: 37937524
[No Abstract] [Full Text] [Related]
28. Identification of new 3-phenyl-1H-indole-2-carbohydrazide derivatives and their structure-activity relationships as potent tubulin inhibitors and anticancer agents: A combined in silico, in vitro and synthetic study.
Saruengkhanphasit R; Butkinaree C; Ornnork N; Lirdprapamongkol K; Niwetmarin W; Svasti J; Ruchirawat S; Eurtivong C
Bioorg Chem; 2021 May; 110():104795. PubMed ID: 33730670
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, biological assessment, and in-Silico studies of 1,2,4-triazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors.
Mohamed HS; Amin NH; El-Saadi MT; Abdel-Rahman HM
Bioorg Chem; 2022 Apr; 121():105687. PubMed ID: 35196595
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, biological evaluation, and molecular docking analysis of phenstatin based indole linked chalcones as anticancer agents and tubulin polymerization inhibitors.
Kode J; Kovvuri J; Nagaraju B; Jadhav S; Barkume M; Sen S; Kasinathan NK; Chaudhari P; Mohanty BS; Gour J; Sigalapalli DK; Ganesh Kumar C; Pradhan T; Banerjee M; Kamal A
Bioorg Chem; 2020 Dec; 105():104447. PubMed ID: 33207276
[TBL] [Abstract][Full Text] [Related]
32. Discovery of pyrazole-carbohydrazide with indole moiety as tubulin polymerization inhibitors and anti-tumor candidates.
Man RJ; Lu T; Zheng CC; Li T; Wu MK; Li DD; He XM
Drug Dev Res; 2023 Feb; 84(1):110-120. PubMed ID: 36433708
[TBL] [Abstract][Full Text] [Related]
33. Recent development and SAR analysis of colchicine binding site inhibitors.
Chen J; Liu T; Dong X; Hu Y
Mini Rev Med Chem; 2009 Sep; 9(10):1174-90. PubMed ID: 19817710
[TBL] [Abstract][Full Text] [Related]
34. Development of tubulin polymerization inhibitors as anticancer agents.
Peerzada MN; Dar MS; Verma S
Expert Opin Ther Pat; 2023 Nov; 33(11):797-820. PubMed ID: 38054831
[TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationships and antiproliferative effects of 1,2,3,4-4H-quinoxaline derivatives as tubulin polymerization inhibitors.
Liang T; Zhou X; Lu L; Dong H; Zhang Y; Xu Y; Qi J; Zhang Y; Wang J
Bioorg Chem; 2021 May; 110():104793. PubMed ID: 33770673
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site.
Li L; Jiang S; Li X; Liu Y; Su J; Chen J
Eur J Med Chem; 2018 May; 151():482-494. PubMed ID: 29649743
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of 1-(benzofuran-3-yl)-4-(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazole derivatives as tubulin polymerization inhibitors.
Qi ZY; Hao SY; Tian HZ; Bian HL; Hui L; Chen SW
Bioorg Chem; 2020 Jan; 94():103392. PubMed ID: 31669093
[TBL] [Abstract][Full Text] [Related]
38. Effect of Hybrid Compounds of Stilbene and Pentadienone on Inhibition of Tubulin Polymerization.
Park J; Koh D; Lee YH; Lim Y; Shin SY
Anticancer Agents Med Chem; 2023; 23(10):1156-1163. PubMed ID: 36797615
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities.
Li G; Wang Y; Li L; Ren Y; Deng X; Liu J; Wang W; Luo M; Liu S; Chen J
Eur J Med Chem; 2020 Sep; 202():112519. PubMed ID: 32650183
[TBL] [Abstract][Full Text] [Related]
40. Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance.
Cheng B; Zhu G; Meng L; Wu G; Chen Q; Ma S
Eur J Med Chem; 2022 Jan; 228():113930. PubMed ID: 34794817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
